fda compounding semaglutide enforcement news november 2025 Important Update: Changes to Compounded Availability New project announcement: HHS‑OIG is

The company called Hims move illegal mass compounding that poses a significant risk to patient safety and said it will pursue legal and regulatory action to protect patients, our intellectual property and the integrity of the US goldstandard drug approval framework. A Novo spokesperson also labelled Hims mass compounding illegal and tied it to what the company described as a pattern of knockoff GLP1 products, as per CNBC

The liquid should be clear and colorless (some compounded formulations may have a very slight tint, which is normal)

So lets say you do have an injury and you already have BPC on board

CAST : Tess Sabrina J